## Pathophysiology of Chronic Inflammation in Pulmonary Fibrosis ### Key Mechanism **Key Point:** Chronic inflammation is characterized by persistent activation of macrophages and fibroblasts, sustained production of pro-fibrotic cytokines, and progressive tissue remodeling rather than acute destruction. ### Cellular and Molecular Basis In idiopathic pulmonary fibrosis (IPF) and other chronic inflammatory lung diseases: 1. **Macrophage activation** — Alveolar macrophages persistently produce TNF-α, TGF-β, and IL-6, which drive fibroblast proliferation and collagen synthesis. 2. **Th1/Th17 response** — Chronic antigenic stimulation (occupational exposure, autoimmune triggers) sustains IFN-γ and IL-17 production, perpetuating inflammation. 3. **Fibroblast-myofibroblast transition** — TGF-β (the master pro-fibrotic cytokine) converts fibroblasts to myofibroblasts, which produce excessive collagen (Types I and III). 4. **Tissue remodeling** — Unlike acute inflammation (which is self-limited), chronic inflammation leads to permanent architectural distortion, honeycombing, and loss of function. ### Histologic Correlation The biopsy finding of **dense fibrosis with chronic inflammatory infiltrate (lymphocytes, plasma cells, macrophages)** is pathognomonic for chronic inflammation driving fibrosis. This is NOT acute neutrophilic inflammation. **High-Yield:** The hallmark of chronic inflammation is **persistent lymphocytic/mononuclear infiltration + tissue destruction/repair (fibrosis)**, not acute neutrophilic exudation. ### Clinical Pearl The 6-month progressive course with pulmonary fibrosis and honeycombing on imaging confirms a chronic inflammatory process. Acute inflammation would present with acute symptoms and would not produce irreversible fibrotic remodeling.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.